Mounjaro should not be used by people with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2)
Brands in those categories are expected to roll out more GLP-1related specific products over the next few months
Retatrutide belongs to the class of drugs known as glucagon-like peptide-1 (GLP-1) agonists, much like Wegovy and Ozempic
However, the regulation of food intake is complex and involves a combination of physiological, psychological, and environmental factors (such as calorie-dense and easily accessible foods)
The monthly fee covers your provider visit, medication, and follow-up care
Women should seek prompt medical advice if they: Have been using retatrutide obtained from an unregulated or online source and experience any adverse symptoms Are pregnant, planning a pregnancy, or breastfeeding and have been offered or are considering retatrutide Have a history of thyroid cancer, pancreatitis, gallbladder disease, or eating disorders and are seeking weight management options Experience unexplained nausea, vomiting, severe abdominal pain, or changes in menstrual cycle while using any GLP-1-based therapy Red flag symptoms requiring urgent medical attention include: Severe or persistent abdominal pain (which may indicate pancreatitis or a gallbladder problem) call 999 or go to A&E if symptoms are severe or accompanied by systemic illness Signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a widespread rash call 999 immediately Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking other glucose-lowering medications Inability to keep fluids down, which may lead to dehydration and kidney problems seek same-day medical advice For women with obesity-related conditions such as PCOS, type 2 diabetes, or cardiovascular risk factors, a structured conversation with a GP or specialist is the safest starting point
